Background: To validate the performance, reproducibility, and reliability of BD automated instruments in order to establish a fully automated clinical microbiology laboratory.
1
Clinical Laboratory Division, Salud Digna para todos I.A.P. Culiacan, Sinaloa, México, 2 Clinical Microbiology Laboratory, National Reference Center, Salud Digna para todos I.A.P., Culiacan, Sinaloa, México, 3 Innovation Division, Salud Digna para todos I.A.P., Culiacan, Sinaloa, México *To whom correspondence should be addressed. jonathan.alcantar@salud-digna.org of sample processing, incubation, and culture processing, as well as innovations in susceptibility testing and microbial identification, has been introduced only in the last decade. [1] [2] [3] The Clinical Microbiology Laboratory at the National Reference Center of Salud Digna para todos I.A.P serves more than 60 diagnostic clinics in 15 states of Mexico. In recent years the volume of specimens, required services, and the number of clinics served have increased rapidly, threatening our capacity to provide timely service. Based on the experience others have reported, [4] [5] [6] we decided to resolve the pressing need to increase our testing capacity and reduce time to result by introducing full automation in the laboratory. For this purpose, we selected the BD Kiestra Work Cell Automation (for sample processing), the BD Phoenix (for antibiotic susceptibility tests), and the BD Bruker MALDI Biotyper (for microbial identification). Because these technologies are different from the conventional methods previously used in our laboratory, it was necessary to validate the performance, reproducibility, and reliability. The present work reports the validation process we used in "the real life context" of a fully functioning clinical laboratory.
Material and Methods
Bacterial strains, colony standard solutions, and samples 
Growth conditions and Agar
Bacterial cultures were incubated at 35 ± 0.5°C for 16h to 20h. The BD CHROMagar Orientation Medium (BD Diagnostic Systems, France) and Mueller Hinton agar (BD Diagnostic System) were used for the BD Kiestra Work Cell Automation (WCA; BD, Drachten, Netherlands) validation and for the Phoenix antibiotic susceptibility test validation, respectively.
Inoculation and streaking
Inoculation and streaking by conventional methods were always performed by the same technician with 1µL and 10µL calibrated loops. For the automated processes 10 µL of sample was inoculated automatically with a sterile pipette and the streaking was performed with the magnetic beads technology (InoqulA). The central streaking throughout the plate followed by zigzag streaking was chosen by a conventional manual inoculation, and the 20 zigzag lines streaking pattern was selected for InoqulA.
Minimal culture time
Control strains were inoculated onto agar plates by conventional methods (calibrated loop) and InoqulA system on CHROMagar medium and were incubated at 35 ± 0.5°C for 24h in aerobic conditions. Every hour, the plates were individually captured utilizing the BD ReadA plate digital imaging system for early growth detection.
Colony counts and sorting cultures
Colony standard solutions and urine samples (10μL) were inoculated onto individual CHROMagar Orientation plates in triplicate to assess the number of colonies. Sorting of positive cultures from 104 urine samples was performed with ReadA Browser and one technician who visually inspected each plate.
Antibiotic susceptibility tests
Disk diffusion according to CLSI M100-S27 (2017) recommendations 7 and Phoenix antibiotic susceptibility tests (ASTs)
were performed with 80 clinical isolates. The disk diffusion plates were incubated at 35 ± 0.5°C in ambient air in the fully-automated BD Kiestra system and the zone of inhibition was measured with The ReadA Browser (BD Kiestra). For the automated procedure, testing was performed with the BD Phoenix PMIC Panels 106 and 108. Disagreements between both methods were considered: minor disagreements (I/R, S/I) or major disagreements (S/R). The interpretation of AST results was made using the BD Xpert System. The results of AST tests were regarded I=Intermediate, S=Susceptible, and R=Resistant according to CLSI MS100-S27 (2017). 7 
Microbial identification by BD Phoenix
The identification of control strains was made with BD Phoenix PMIC-106/108 panels. The ID broth was inoculated with bacterial colonies (in duplicate from 20 different cultures plates) from a pure culture adjusted to a 0.5 McFarland standard by using a BD PhoenixSpec Nephelometer. Identification was made according to the manufacturer recommendations.
Microbial identification by mass spectrometry
A thin film of bacterial material was deposited on a mass spectrometry MSP96 (Bruker Daltonik) steel plate and overlaid with 1µL matrix solution (saturated solution of α-cyano-4-hydroxy-cinnamic acid in 50% acetonitrile and 2.5% trifluoroacetic acid). Each microorganism was tested in duplicate from 20 different cultures plates from each strain. Identification was performed with a Microflex LT mass spectrometer (Bruker Daltonik, Bremen, Germany). Mass spectrometry analysis and data interpretation
Spectra were recorded and imported into the MALDI Biotyper software (Bruker Daltonik), and the spectra were analyzed by standard pattern matching. The results were expressed as scores ranging from 0 to 3. Scores below 2 were regarded as unreliable, and scores ≥2.0 were regarded as a reliable identification of species. Results were considered definitive when identifications by mass spectrometry in duplicate tests matched exactly and scores were ≥2.0. In cases of discrepant results, samples were retested. If scores were <2.0 after retesting, identification was considered unsuccessful.
Statistical analysis
Descriptive statistics were performed to determine data distribution. If normality failed, data was tested using a non-parametric test. For the colony counting, the MannWhitney (U) test was used, and for minimal culture time, the 95% CI was calculated. Agreement between manual and automated methods was evaluated with Kappa index, the magnitude of kappa was considered to be poor (<0.40), good (0.4 to 0.75), or excellent (>0.75). Data analysis was done using GraphPad prism software V 6.0 (Graphpad Software, Inc. La Jolla, CA; USA).
Results

Validation of BD Kiestra WCA
The BD Kiestra WCA enables automated sample processing, plate incubation, and digital imaging with the ReadA browser. We evaluated each process separately to determine the reliability of the system.
Sample processing
To evaluate the automated processing of liquid samples by the BD Kiestra InoqulA, we compared the number of isolated colonies obtained between the inoculation with calibrated loops (1µL and 10µL) and the inoculation with InoqulA (10µL). For this, serial ten-fold dilutions of E. coli were inoculated onto CHROMagar Orientation medium. Figure 1 shows a comparison between inoculation and streaking for conventional methods (calibrated loops) versus InoqulA. For conventional methods (CM), we test if there were significant differences between the 1µL inoculum than the 10µL inoculum. We obtained more colonies with the 10µL inoculum than with 1µL inoculum for suspensions with ≤10 6 CFU/mL, but no significant differences were observed with ≥10 7 CFU/mL solutions. ( Figure 1A) . Moreover, we obtained more colonies with InoqulA than CM with the 10µL inoculum (P<0.05) ( Figure 1B ) except in high CFU solutions in which the counts were very similar between both methods. A representative picture of streaking samples for the manual and automated process is shown in the Figure 1C .
As can be seen, we were able to isolate a larger number of single colonies with InoqulA compared to CM.
Minimal culture time
We compared incubation of plates in a standard incubator and in the Kiestra ReadA Compact system to determine if there was a difference in time to detection of growth. A total volume of 10µL of a standardized solution (10 6 CFU/ mL) of four quality control strains was inoculated onto CHROMagar plates with InoqulA and then were incubated under appropriate conditions in a standard incubator for CM and in the BD Kiestra Incubators (ReadA Compact system).
Photographs from each plate processed by both methods were taken with ReadA browser each hour for 20 hours. We observed that all control strains were recovered in less time in the BD Kiestra incubators than CM. For example, E. coli and S. aureus were recovered in ~7h and 9h, respectively, in Kiestra compared with 10h and 13h with the conventional methods ( Table 1) .
Validation of the ReadA browser for plates reading, and sorting cultures
We assessed the ability of the ReadA browser to automatically screen culture plates for significant growth. Serial 10-fold dilutions of E. coli and S. aureus were prepared manually, and then 10µL of each suspension was inoculated in triplicate onto CHROMagar orientation media. Following incubation in the ReadA Compact, colony counts were determined using the ReadA browser and compared with manual assessment of the culture plates (always by the same technologist). There was good agreement between ReadA browser and the manual colony counts (κ=0.824, 95%CI=0.633-1.00; (Table 2B ). In addition, we found that the sensitivity of the ReadA browser was 100% (95% CI=89.28-1.00) and the specificity 88.89% (95% CI=79.58-94.26). Therefore the ReadA browser it is suitable for automated colony counts and identification of positive cultures and could replace the manual procedure.
Validation of the BD Phoenix in antibiotic susceptibility test (AST)
The disk diffusion antibiotic susceptibility test on MuellerHinton agar was compared with the BD Phoenix instrument tests. A total of 28 antibiotics were tested with the 4 control strains. The disk diffusion method was performed according to the CLSI guidelines (M100-S27) 2017 7 . Table 3 summarizes the results of concordance analysis between the disk diffusion method and the BD Phoenix system. From 80 samples analyzed, we observed concordance between both methods in 96.25% of the tests; in addition, only minor disagreements were observed in 3.75%. These disagreements were observed in the E. faecalis strain in the Tetracycline (I/R) and Erythromycin (I/S) antibiotics. No major disagreements were observed.
Microbial identification in the BD Phoenix and MALDI-Biotyper
Microbial identification was tested in the BD Phoenix and BD Bruker MALDI Biotyper System (mass spectrometry) with the E. coli, E. faecalis, S. aureus, and Ps. aeruginosa quality control strains. Twenty independent 0.5 McFarland solutions were analyzed in both instruments. The BD Phoenix correctly identified all samples from control strains at species level ( Table 4 ).
In addition, for the same inoculum, the MALDI-Biotyper correctly identified samples from control strains at the species level (Score≥2.0) ( Table 4 ). The concordance among both instruments was very high (κ=1, 95% CI=1.00). Our results show that both instruments are suitable for the automated microbial identification.
Discussion
To our knowledge, this is the first report in which the BD Kiestra, BD Phoenix, and BD MALDI-Biotyper were evaluated jointly with the objective for the implementation of a fully automated microbiology laboratory. Previous reports show that automated microbiology specimen processing platforms result in reduced workload and time waiting for results. [2] [3] [4] Additionally, when compared with manual inoculation of urine specimens with a calibrated-loop, the InoqulA was more precise and reproducible. [1] [2] [3] [4] [5] [6] This is concordant with our observations (Figure 1 ) in the comparison of the InoqulA with the manual inoculation. We also assessed the ability to obtain isolated colonies for identification and susceptibility tests using automated inoculation of culture plates. Many laboratories will inoculate 1µL of urine rather than the recommended 10µL because of the difficulties obtaining isolated colonies when high-grade bacteriuria is present. 2, 6 In this study, we compared manual inoculation of 1µL and 10µL of urine with 10µL with the InoqulA. Consistent with the Froment and Quiblier reports 4, 6 we obtained more isolated colonies with the 10µL inoculum than with the 1µL on whole plates ( Figure 1A) . The 10µL inoculum increased the frequency of single-colony recovery from 10 5 -10 6 CFU/mL. For high CFU/mL solutions ( 10 7 - 10 8 ), there were no differences in colony recovery in manual streaking ( Figure 1A ). Otherwise, we were able to isolate more colonies with InoqulA than CM ( Figure 1B) . Similar results were reported in previous works, [4] [5] [6] demonstrating the advantage of automated plate inoculation. In addition, InoqulA greatly decreased the requirement of subculture for bacterial isolation, which is consistent with previous reports in which the use of InoqulA resulted in a significant reduction of bacterial subcultures. In consequence, laboratory workload, samples processing time, and costs were reduced. 2, 6 We evaluated the accuracy of imaging ReadA browser software in colony counts and culture sorting and found good The aim of this work was not to evaluate the impact of automation on laboratory workflow; however, we observed a significant reduction in workload time in the laboratory with the use of these automated instruments compared to conventional methods. For example, we obtained identification and antibiotic susceptibility test results for urine samples in ~2 days compared with 3 or more days previously. This is consistent with the time savings others have observed with these automated instruments when used separately. 2, 3, 5, 6, 17 In our experience, the use of the BD Kiestra, BD Phoenix and BD Bruker MALDI-Biotyper instruments in combination have improved traceability of the samples in all processes starting in sample inoculation, until to the direct identification and antibiotic susceptibility test from clinical samples (data not published), and may also have a positive impact on patient care and the timely treatment of microbial infections in patients.
In conclusion, we obtained higher accuracy and reliability with the instruments tested in this study compared with conventional methods.
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